Mitsubishi UFJ Morgan Stanley Securities’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-610
Closed -$93K 19
2020
Q4
$93K Buy
+610
New +$93K 0.08% 24